semaglutide causing depression The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy GLP-1s associated with reduced risk
Description
A 12mg dose still exceeds a 10mg vial at any concentration
Diabetes itself increases NAION risk, creating particularly dangerous situations when patients take GLP-1 medications that multiply already elevated baseline risk
Mitochondrial Dynamics and Mitophagy in Skeletal Muscle Health and Aging
however, it did not reach statistical significance
